Connection
Margret Bock to Risk Factors
This is a "connection" page, showing publications Margret Bock has written about Risk Factors.
|
|
Connection Strength |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_left.gif) |
|
![](https://profiles.ucdenver.edu/Framework/Images/connection_right.gif) |
|
0.209 |
|
|
|
-
Bock ME, Wall L, Dobrec C, Chandran M, Goebel J. Management of dyslipidemia in pediatric renal transplant recipients. Pediatr Nephrol. 2021 01; 36(1):51-63.
Score: 0.068
-
Strommen AM, Moss MC, Goebel J, Bock M. Donor-specific antibodies in a pediatric kidney transplant population-Prevalence and association with antiproliferative drug dosing. Pediatr Transplant. 2019 09; 23(6):e13511.
Score: 0.066
-
Bock ME, Bobrowski AE, Bhat R. Utility of thrombophilia screening in pediatric renal transplant recipients. Pediatr Transplant. 2019 02; 23(1):e13314.
Score: 0.063
-
Khalighi MA, Wang S, Henriksen KJ, Bock M, Keswani M, Chang A, Meehan SM. Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients. Pediatr Nephrol. 2015 Jun; 30(6):953-9.
Score: 0.012